Sign inJoin waitlistJoin the waitlist

MF

Monica Fornier

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · · ·

History

Memorial Sloan Kettering Monmouth
2026–Present

National Cancer Institute of Milan
1997–2000
Memorial Sloan Kettering Cancer Center
1995–1997
National Cancer Institute of Milan
1992–1995
University of Milan Italy
1988–1992

Research

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
Journal of Clinical Oncology · 2001 · 453 citations
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer
Journal of Clinical Oncology · 2007 · 228 citations
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study
Journal of the American Geriatrics Society · 2006 · 192 citations

CH
Clifford Hudis
29 papers
LN
Larry Norton
21 papers
AS
Andrew Seidman
19 papers
GD
Gabriella D'Andrea
17 papers
CD
Chau Dang
15 papers
AF
Azeez Farooki
12 papers
DL
Diana Lake
12 papers
PM
Patrick Morris
12 papers
SM
Shanu Modi
11 papers
MT
Maria Theodoulou
10 papers
MM
Mary Moynahan
9 papers
MD
Maura Dickler
9 papers

Clinical trials

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
2022–2026
Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Principal investigator · Completed · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2009–2018
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2003–2006